Top headlines: SII buys 50% stake in vial maker; China tech stocks slump

Business Standard brings you the top headlines this evening

Serum Institute picks up 50% in glass vial maker Schott's Indian JV
 

Vaccine maker Serum Institute of India (SII) has picked up a 50 per cent stake in specialty glass company Schott AG’s Indian joint venture, Schott Kaisha, from the former co-owners Kairus Dadachanji and Shapoor Mistry for an undisclosed sum.

While the deal helps SII to have more control over its supply chain (glass vials are a critical component of vaccine packaging), it also helps the Kaisha group to focus on their other pharmaceutical ventures. Read more

India asks US court to